These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32282391)
1. Nonpharmacologic Treatment for Heart Failure: A Review of Implantable Carotid Baroreceptor Stimulators As a Therapeutic Option. Malangu B; Lanier GM; Frishman WH Cardiol Rev; 2021; 29(1):48-53. PubMed ID: 32282391 [TBL] [Abstract][Full Text] [Related]
2. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy. Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593 [TBL] [Abstract][Full Text] [Related]
3. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany. Borisenko O; Müller-Ehmsen J; Lindenfeld J; Rafflenbeul E; Hamm C BMC Cardiovasc Disord; 2018 Aug; 18(1):163. PubMed ID: 30092774 [TBL] [Abstract][Full Text] [Related]
4. Electrical carotid baroreceptor stimulation. Schmidli J; von Allmen RS; Mohaupt MG Wien Med Wochenschr; 2014 Dec; 164(23-24):508-14. PubMed ID: 25411011 [TBL] [Abstract][Full Text] [Related]
5. Baroreceptor stimulation for resistant hypertension: first implantation in France and literature review. Courand PY; Feugier P; Workineh S; Harbaoui B; Bricca G; Lantelme P Arch Cardiovasc Dis; 2014 Dec; 107(12):690-6. PubMed ID: 25445751 [TBL] [Abstract][Full Text] [Related]
6. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction. Halbach M; Hickethier T; Madershahian N; Müller-Ehmsen J Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1465-9. PubMed ID: 25382103 [TBL] [Abstract][Full Text] [Related]
7. Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States. Bisognano J; Schneider JE; Davies S; Ohsfeldt RL; Galle E; Stojanovic I; Deering TF; Lindenfeld J; Zile MR BMC Cardiovasc Disord; 2021 Mar; 21(1):155. PubMed ID: 33771104 [TBL] [Abstract][Full Text] [Related]
8. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464 [TBL] [Abstract][Full Text] [Related]
9. Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure. Doumas M; Faselis C; Tsioufis C; Papademetriou V Curr Hypertens Rep; 2012 Jun; 14(3):238-46. PubMed ID: 22457242 [TBL] [Abstract][Full Text] [Related]
10. [Anesthesia management in implantation of baroreceptor stimulators]. Werner T; Lebar L; Wittmann S; Keyser A; Fischer M; Schmidli J; Graf BM; Zausig YA Anaesthesist; 2015 Sep; 64(9):683-8. PubMed ID: 26275386 [TBL] [Abstract][Full Text] [Related]
11. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective. Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H Curr Heart Fail Rep; 2016 Apr; 13(2):71-6. PubMed ID: 26879389 [TBL] [Abstract][Full Text] [Related]
13. Carotid baroreceptor stimulation: a promising approach for the management of resistant hypertension and heart failure. Doumas M; Faselis C; Kokkinos P; Anyfanti P; Tsioufis C; Papademetriou V Curr Vasc Pharmacol; 2014 Jan; 12(1):30-7. PubMed ID: 23905599 [TBL] [Abstract][Full Text] [Related]
14. The baroreceptor as a therapeutic target for heart failure. Gronda E; Lovett EG; Tarascio M; Georgakopoulos D; Grassi G; Vanoli E J Cardiovasc Transl Res; 2014 Apr; 7(3):301-9. PubMed ID: 24563340 [TBL] [Abstract][Full Text] [Related]
15. A Comparative Review of Vagal Nerve Stimulation Versus Baroreceptor Activation Therapy in Cardiac Diseases. Arya AV; Bisht H; Tripathi A; Agrawal M; Konat A; Patel J; Mozumder K; Shah D; Chaturvedi D; Sharma K Cureus; 2023 Jun; 15(6):e40889. PubMed ID: 37492836 [TBL] [Abstract][Full Text] [Related]
16. Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension. Groenland EH; Spiering W Curr Hypertens Rep; 2020 Mar; 22(4):27. PubMed ID: 32166464 [TBL] [Abstract][Full Text] [Related]